Pall Acquires Chromatography Business from Ciphergen
Pall Corporation announced that it has completed the acquisition of the BioSepra Process Division from Ciphergen Biosystems, Inc. The purchase price was $32 million, net of cash and debt. The BioSepra Process Division develops, manufactures and markets chromatography sorbents that greatly simplify protein purification for drug development and production. Eric Krasnoff, Chairman and CEO of Pall Corporation, said, "The addition of this innovative, broad range of chromatography chemistries strengthens our ability to serve the needs of biotechnology customers. The marriage of BioSepra's capabilities and Pall's extensive existing product portfolio allows customers to benefit from a highly integrated 'Total Fluid Management' approach."
Pall plans to establish additional Process Proteomics Service Centers to assist customers in selecting and optimizing sorbents and membranes for the purification of proteins used in the production of therapeutic proteins and other bioprocess applications.
Pall and Ciphergen have also entered into a collaboration for process proteomics, based on the combination of Ciphergen's ProteinChip® technology and BioSepra's leading chromatography products.
Topics
Organizations
Other news from the department business & finance
These products might interest you

Hahnemühle LifeScience Catalogue Industry & Laboratory by Hahnemühle
Wide variety of Filter Papers for all Laboratory and Industrial Applications
Filtration Solutions in the Life Sciences, Chemical and Pharmaceutical Sectors

Hydrosart® Microfilter by Sartorius
Hydrophilic microfilters for bioprocesses
Minimal protein adsorption and high flow rates

Hydrosart® Ultrafilter by Sartorius
Efficient ultrafiltration for biotech and pharma
Maximum flow rates and minimum protein loss with Hydrosart® membranes

Polyethersulfone Microfilter by Sartorius
Biotechnological filtration made easy
Highly stable 0.1 µm PESU membranes for maximum efficiency

Sartobind® Rapid A by Sartorius
Efficient chromatography with disposable membranes
Increase productivity and reduce costs with fast cycle times

Sartopore® Platinum by Sartorius
Efficient filtration with minimal protein adsorption
Reduces rinsing volume by 95 % and offers 1 m² filtration area per 10"

Polyethersulfone Ultrafilter by Sartorius
Reliable filtration with PESU membranes
Perfect for biotechnology and pharmaceuticals, withstands sterilisation and high temperatures

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Chromatography
Chromatography enables us to separate, identify and thus understand complex substances. Whether in the food industry, pharmaceutical research or environmental analysis - chromatography opens up a treasure trove of information about the composition and quality of our samples. Discover the fascinating world of chromatography!

Topic World Chromatography
Chromatography enables us to separate, identify and thus understand complex substances. Whether in the food industry, pharmaceutical research or environmental analysis - chromatography opens up a treasure trove of information about the composition and quality of our samples. Discover the fascinating world of chromatography!
Last viewed contents

Collaboration to develop vaccine against Helicobacter pylori - Core Facility Animal Models and start-up company Iguana cooperate
Cytena GmbH to be acquired by CELLINK

Merck achieved strong business results in the first quarter - Organic sales growth of 12.2% driven by all three business sectors, especially Life Science

Merck Closes Mirus Bio Acquisition, Bolstering Viral Vector Bioprocessing Offering - Advances Merck’s ambition to provide fully integrated and comprehensive solution for viral vector manufacturing
Category:Biology_timelines

Is a "buttery" molecule behind cystic fibrosis flare-ups?
